Panion & Bf Biotech Inc. (1760.TW)
- Previous Close
69.90 - Open
70.20 - Bid 69.70 x --
- Ask 70.00 x --
- Day's Range
69.30 - 70.80 - 52 Week Range
56.00 - 104.50 - Volume
50,598 - Avg. Volume
135,154 - Market Cap (intraday)
6.002B - Beta (5Y Monthly) -0.28
- PE Ratio (TTM)
48.28 - EPS (TTM)
1.45 - Earnings Date May 12, 2025
- Forward Dividend & Yield 1.50 (2.14%)
- Ex-Dividend Date Jun 13, 2024
- 1y Target Est
--
Panion & Bf Biotech Inc., a biotechnology pharmaceutical company, provides western medicines, cosmetics, and health care products in Taiwan, the United States, China, Hong Kong, and internationally. The company offers products in the areas of antibody, respiratory, gastrointestinal, Covid-19 IVD, antigen, anti-aging, active pharmaceutical ingredients, disease treatment, prevention, and veterinary products. It also offers nephrology, dermatology, pain management, hospital and household sanitization, and personal hygiene services. Panion & Bf Biotech Inc. was founded in 1974 and is headquartered in Taipei, Taiwan.
www.pbf.com.twRecent News: 1760.TW
View MorePerformance Overview: 1760.TW
Trailing total returns as of 5/9/2025, which may include dividends or other distributions. Benchmark is TSEC CAPITALIZATION WEIGHTED ST (^TWII) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 1760.TW
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 1760.TW
View MoreValuation Measures
Market Cap
5.99B
Enterprise Value
6.14B
Trailing P/E
48.21
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.95
Price/Book (mrq)
3.12
Enterprise Value/Revenue
3.02
Enterprise Value/EBITDA
15.47
Financial Highlights
Profitability and Income Statement
Profit Margin
6.14%
Return on Assets (ttm)
3.99%
Return on Equity (ttm)
6.50%
Revenue (ttm)
2.03B
Net Income Avi to Common (ttm)
124.52M
Diluted EPS (ttm)
1.45
Balance Sheet and Cash Flow
Total Cash (mrq)
558.37M
Total Debt/Equity (mrq)
37.93%
Levered Free Cash Flow (ttm)
93.15M